IMRIS Inc. IMRSQ

Company Overview

IMRIS Inc. (formerly TSX/NASDAQ: IMRS, OTC: IMRSQ) was a Canadian medical technology company focused on advanced intraoperative imaging and surgical visualization systems for hospitals and neurosurgical centers. The company operated within the medical devices, image-guided therapy, and healthcare technology industries, primarily developing integrated operating room environments that combined magnetic resonance imaging (MRI), computed tomography (CT), and surgical workflow technologies. Its core value proposition centered on enabling surgeons to obtain real-time imaging during procedures without moving patients between operating and diagnostic rooms.

The company’s primary revenue drivers historically included sales and installation of its VISIUS Surgical Theatre platforms, service agreements, maintenance contracts, and related imaging integration solutions. IMRIS primarily served large hospitals, academic medical centers, and specialty neurosurgical institutions across North America, Europe, the Middle East, and Asia-Pacific. The company was founded in Canada and evolved from a niche intraoperative MRI developer into a broader surgical workflow and imaging integration provider before experiencing financial distress. Public filings and market records indicate the company ultimately entered restructuring and insolvency proceedings, with its shares later trading on the OTC market under the symbol IMRSQ.